Viewing Study NCT04977804


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-01-01 @ 8:47 AM
Study NCT ID: NCT04977804
Status: WITHDRAWN
Last Update Posted: 2023-12-07
First Post: 2021-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eccentric Resistance Training With Blood Flow Restriction on Muscle Function
Sponsor: Utah State University
Organization:

Study Overview

Official Title: Effects of Blood Flow Restriction During Multiple-joint Eccentric Resistance Training on Muscle Morphology and Function of the Lower Body.
Status: WITHDRAWN
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: A key faculty at our college who was helping with the project left the college.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study will determine the effects of adding blood flow restriction to eccentric training to assess whether this increases the improvements of muscle strength and size.
Detailed Description: Subjects will be randomly assigned to two groups: an eccentric only resistance training group or an eccentric training plus blood flow restriction group. Subjects will train at a moderately low intensity on a multiple-joint eccentric device. Those in the blood flow restriction will wear blood flow restriction cuffs on their upper thighs to reduce blood flow during the brief protocol. The training session will occur twice per week and will last \~5 minutes, including a one minute warm up, a one minute cool down and a three minute workout phase. The training program will last 7 weeks. Testing will be conducted at baseline (following a one session familiarization), 4 weeks and after the end of the 7 week training period. Assessments will focus on muscle strength, function, and morphology (size).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: